AllianceBernstein’s Evolent Health EVH Stock Holding History

AllianceBernstein’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$495K	Sell	123,790 -3,200	-3%	-$10.2K	﹤0.01%	2637
2025 Q4	$508K	Sell	126,990 -103	-0.1%	-$573	﹤0.01%	2656
2025 Q3	$1.08M	Hold	127,093	–	–	﹤0.01%	2321
2025 Q2	$1.43M	Hold	127,093	–	–	﹤0.01%	2100
2025 Q1	$1.2M	Sell	127,093 -660	-0.5%	-$6.67K	﹤0.01%	2148
2024 Q4	$1.44M	Sell	127,753 -100,004	-44%	-$1.76M	﹤0.01%	2132
2024 Q3	$6.44M	Buy	227,757 +64,639	+40%	+$1.67M	﹤0.01%	1407
2024 Q2	$3.12M	Sell	163,118 -144,143	-47%	-$3.68M	﹤0.01%	1710
2024 Q1	$10.1M	Sell	307,261 -40,551	-12%	-$1.29M	﹤0.01%	1156
2023 Q4	$11.5M	Buy	347,812 +15,398	+5%	+$436K	﹤0.01%	1086
2023 Q3	$9.05M	Buy	332,414 +38,084	+13%	+$1.06M	﹤0.01%	1137
2023 Q2	$8.92M	Buy	294,330 +167,829	+133%	+$5.43M	﹤0.01%	1183
2023 Q1	$4.1M	Sell	126,501 -23,169	-15%	-$733K	﹤0.01%	1477
2022 Q4	$4.2M	Buy	149,670 +58,870	+65%	+$1.69M	﹤0.01%	1512
2022 Q3	$3.26M	Hold	90,800	–	–	﹤0.01%	1600
2022 Q2	$2.79M	Hold	90,800	–	–	﹤0.01%	1750
2022 Q1	$2.93M	Buy	90,800 +200	+0.2%	+$5.24K	﹤0.01%	1864
2021 Q4	$2.51M	Sell	90,600 -11,600	-11%	-$333K	﹤0.01%	2005
2021 Q3	$3.17M	Sell	102,200 -5,500	-5%	-$132K	﹤0.01%	1873
2021 Q2	$2.27M	Buy	107,700 +14,400	+15%	+$288K	﹤0.01%	2117
2021 Q1	$1.89M	Buy	93,300 +2,100	+2%	+$39.9K	﹤0.01%	2140
2020 Q4	$1.46M	Hold	91,200	–	–	﹤0.01%	2146
2020 Q3	$1.13M	Sell	91,200 -2,000	-2%	-$23.5K	﹤0.01%	2124
2020 Q2	$664K	Sell	93,200 -5,100	-5%	-$34.2K	﹤0.01%	2430
2020 Q1	$534K	Buy	98,300 +13,000	+15%	+$116K	﹤0.01%	2320
2019 Q4	$772K	Sell	85,300 -38	-0%	-$309	﹤0.01%	2382
2019 Q3	$614K	Buy	85,338 +38	+0%	+$273	﹤0.01%	2458
2019 Q2	$678K	Hold	85,300	–	–	﹤0.01%	2474
2019 Q1	$1.07M	Hold	85,300	–	–	﹤0.01%	2218
2018 Q4	$1.7M	Sell	85,300 -700	-0.8%	-$16.2K	﹤0.01%	1917
2018 Q3	$2.44M	Hold	86,000	–	–	﹤0.01%	1807
2018 Q2	$1.81M	Buy	86,000 +24,277	+39%	+$459K	﹤0.01%	1996
2018 Q1	$880K	Buy	61,723 +1,123	+2%	+$16.1K	﹤0.01%	2318
2017 Q4	$745K	Buy	60,600 +2,100	+4%	+$29.6K	﹤0.01%	2421
2017 Q3	$1.04M	Hold	58,500	–	–	﹤0.01%	2257
2017 Q2	$1.48M	Buy	58,500 +34,700	+146%	+$835K	﹤0.01%	2049
2017 Q1	$531K	Hold	23,800	–	–	﹤0.01%	2515
2016 Q4	$352K	Buy	23,800 +5,400	+29%	+$106K	﹤0.01%	2680
2016 Q3	$453K	Buy	18,400 +3,900	+27%	+$91.2K	﹤0.01%	2563
2016 Q2	$278K	Buy	+14,500	New	+$199K	﹤0.01%	2706

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein's EVH Position: Q1 2026 in Review

AllianceBernstein reduced its Evolent Health (EVH) stake by 2.5% in Q1 2026, selling an estimated $10.2K and leaving 123,790 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

AllianceBernstein first reported a position in EVH in Q2 2016 and has held it in 40 quarters since. The position peaked at $11.5M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

AllianceBernstein held 123,790 shares of Evolent Health worth $495K as of Q1 2026.
AllianceBernstein sold 3,200 Evolent Health shares in Q1 2026, an estimated $10.2K.
Evolent Health made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2637 holding.
AllianceBernstein first reported a position in Evolent Health in Q2 2016 and has held it in 40 quarters since.
AllianceBernstein's Evolent Health position peaked at $11.5M in Q4 2023.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.